Access to Treatment Atlas: compare lung cancer treatment access across Europe

The Access to Treatment Atlas has been redesigned to make it easier to explore, compare and share information on lung cancer treatment access across Europe.

Alongside a completely refreshed look and feel, the new platform offers improved navigation, enhanced country and treatment pages, and a range of new features designed to make the Atlas even more valuable for patient advocates and everyone working to improve access to lung cancer care.

You can now:

• Compare reimbursement status across countries and treatments, making it easier to understand how access varies across Europe.

• Access dedicated resources on lung cancer screening, biomarker testing and clinical trials directly within the platform.

• Explore an interactive map with a modern design and clear visual indicators.

• Search, filter and compare information more easily using improved navigation and filtering tools.

• Browse the Atlas in the languages of countries across the WHO European Region.

• Copy and share direct links to individual treatment pages.

• Use the Atlas seamlessly across desktop, tablet and mobile devices.

• Access integrated guidance throughout the platform, making it easier to navigate and get the most from the available information.

The Atlas has also been designed to grow with the lung cancer community. If you notice information that is missing or out of date, or if there are treatments and resources available in your country that are not yet included, you can now submit feedback directly through the platform. Your contributions will help us keep the Atlas accurate, relevant and up to date for everyone.

Whether you're looking for information in your own country, comparing access across Europe, or finding resources to support your advocacy, we hope the new Atlas makes that work simpler than ever.